Serotonin 2A Receptor (5-HT


Journal

ACS pharmacology & translational science
ISSN: 2575-9108
Titre abrégé: ACS Pharmacol Transl Sci
Pays: United States
ID NLM: 101721411

Informations de publication

Date de publication:
09 Apr 2021
Historique:
received: 05 11 2020
entrez: 16 4 2021
pubmed: 17 4 2021
medline: 17 4 2021
Statut: epublish

Résumé

Serotonergic psychedelics are defined as compounds having serotonin 2A receptor (5-HT

Identifiants

pubmed: 33860178
doi: 10.1021/acsptsci.0c00189
pmc: PMC8033611
doi:

Types de publication

Journal Article

Langues

eng

Pagination

479-487

Informations de copyright

© 2021 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

PLoS One. 2017 Apr 20;12(4):e0175642
pubmed: 28426733
Curr Top Behav Neurosci. 2018;36:361-391
pubmed: 28512684
Neuropharmacology. 2015 Dec;99:546-53
pubmed: 26318099
Expert Opin Drug Discov. 2015 May;10(5):449-61
pubmed: 25835573
Handb Exp Pharmacol. 2018;252:227-260
pubmed: 29532180
Drug Test Anal. 2020 Aug;12(8):1154-1170
pubmed: 32415729
Biochem Pharmacol. 2018 Dec;158:27-34
pubmed: 30261175
Biochem Pharmacol. 2020 Jul;177:113934
pubmed: 32224136
Eur Rev Med Pharmacol Sci. 2015 Sep;19(17):3270-81
pubmed: 26400534
ACS Chem Neurosci. 2019 Nov 12;:
pubmed: 31657895
Pharmacol Rev. 2016 Apr;68(2):264-355
pubmed: 26841800
Mol Pharmacol. 2006 Dec;70(6):1956-64
pubmed: 17000863
Chem Res Toxicol. 2016 Jan 19;29(1):96-100
pubmed: 26669514
Mol Pharmacol. 2007 Nov;72(5):1200-9
pubmed: 17715398
ACS Chem Biol. 2016 Feb 19;11(2):400-8
pubmed: 26569370
ACS Chem Neurosci. 2020 May 6;11(9):1238-1244
pubmed: 32212672
Pharmacol Ther. 2004 Feb;101(2):131-81
pubmed: 14761703
Arch Toxicol. 2020 Oct;94(10):3449-3460
pubmed: 32627074
Cell. 2020 Sep 17;182(6):1574-1588.e19
pubmed: 32946782
ACS Chem Neurosci. 2016 Nov 16;7(11):1614-1619
pubmed: 27564969
Nat Struct Mol Biol. 2019 Feb;26(2):121-128
pubmed: 30723326
Arch Toxicol. 2020 Apr;94(4):1085-1133
pubmed: 32249347
Anal Chem. 2019 Dec 17;91(24):15444-15452
pubmed: 31725281
J Mol Graph Model. 2013 Nov;46:41-51
pubmed: 24121518
Biochem Pharmacol. 2019 Nov;169:113623
pubmed: 31472128
Curr Top Behav Neurosci. 2018;36:1-43
pubmed: 28401524
Biochem Pharmacol. 2020 Dec;182:114251
pubmed: 32998000

Auteurs

Eline Pottie (E)

Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Campus Heymans, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.

Olga V Kupriyanova (OV)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan 420008, Russian Federation.
Kazan State Medical University, Kazan 420012, Russian Federation.

Asher L Brandt (AL)

College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5, Canada.

Robert B Laprairie (RB)

College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5, Canada.
Department of Pharmacology, College of Medicine, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada.

Vadim A Shevyrin (VA)

Institute of Chemistry and Technology, Ural Federal University, Ekaterinburg 620002, Russian Federation.

Christophe P Stove (CP)

Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Campus Heymans, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.

Classifications MeSH